Applicant, as named in the Orange Book

Axsome

Next listed expiry: Auvelity on 20 Jan 2043. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Auvelity · 2 strengths bupropion hydrochloride; dextromethorphan hydrobromide	bupropion hydrochloride; dextromethorphan hydrobromide	215430	20 Jan 2043	patent, carve-out possible
Symbravo meloxicam; rizatriptan benzoate	meloxicam; rizatriptan benzoate	215431	10 Mar 2045	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.